These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23438627)

  • 1. 'FREEDOM' trial: have the interventional cardiologists lost their freedom?
    Jariwala P; Chandra S
    Indian Heart J; 2013; 65(1):114-6. PubMed ID: 23438627
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for multivessel revascularization in patients with diabetes.
    Farkouh ME; Domanski M; Sleeper LA; Siami FS; Dangas G; Mack M; Yang M; Cohen DJ; Rosenberg Y; Solomon SD; Desai AS; Gersh BJ; Magnuson EA; Lansky A; Boineau R; Weinberger J; Ramanathan K; Sousa JE; Rankin J; Bhargava B; Buse J; Hueb W; Smith CR; Muratov V; Bansilal S; King S; Bertrand M; Fuster V;
    N Engl J Med; 2012 Dec; 367(25):2375-84. PubMed ID: 23121323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational studies of drug-eluting stents--some are more equal than others.
    Austin D; Oldroyd KG; Pell JP
    EuroIntervention; 2009 Jan; 4(4):419, 421, 423. PubMed ID: 19284062
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for multivessel revascularization in patients with diabetes: the FREEDOM trial.
    Farmer JA
    Curr Atheroscler Rep; 2014 Jul; 16(7):426. PubMed ID: 24873916
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetes.
    Doggrell SA
    Expert Opin Pharmacother; 2013 Jun; 14(9):1269-73. PubMed ID: 23641928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to revascularize patients with diabetes mellitus: bypass or stents and drugs?
    Elsässer A; Möllmann H; Nef HM; Hamm CW
    Clin Res Cardiol; 2006 Apr; 95(4):195-203. PubMed ID: 16598587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting.
    Bansilal S; Farkouh M; Sharma S; Fuster V
    Indian Heart J; 2007; 59(2 Suppl B):B72-82. PubMed ID: 19153439
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of the U.S. ARRIVE 1 registry: 2-year outcomes.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):446-7. PubMed ID: 18819146
    [No Abstract]   [Full Text] [Related]  

  • 9. Compelling evidence for coronary-bypass surgery in patients with diabetes.
    Hlatky MA
    N Engl J Med; 2012 Dec; 367(25):2437-8. PubMed ID: 23121324
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary revascularisation in patients with diabetes: a chance to be better.
    Windecker S; Stefanini GG
    Evid Based Med; 2013 Dec; 18(6):e59. PubMed ID: 23645889
    [No Abstract]   [Full Text] [Related]  

  • 11. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al.
    Marx N
    Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069
    [No Abstract]   [Full Text] [Related]  

  • 12. Revascularization strategies in patients with diabetes.
    Serruys PW; Farooq V
    N Engl J Med; 2013 Apr; 368(15):1454-5. PubMed ID: 23574130
    [No Abstract]   [Full Text] [Related]  

  • 13. Revascularization strategies in patients with diabetes.
    Ryding A
    N Engl J Med; 2013 Apr; 368(15):1454. PubMed ID: 23574129
    [No Abstract]   [Full Text] [Related]  

  • 14. Revascularization strategies in patients with diabetes.
    Piek JJ; de Winter RJ; Tijssen JG
    N Engl J Med; 2013 Apr; 368(15):1453-4. PubMed ID: 23574128
    [No Abstract]   [Full Text] [Related]  

  • 15. Revascularization strategies in patients with diabetes.
    Alfonso F; Hernandez R
    N Engl J Med; 2013 Apr; 368(15):1453. PubMed ID: 23574127
    [No Abstract]   [Full Text] [Related]  

  • 16. Revascularization strategies in patients with diabetes.
    Farkouh ME; Domanski M; Fuster V
    N Engl J Med; 2013 Apr; 368(15):1455-6. PubMed ID: 23574126
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of everolimus-eluting stents or bypass surgery for coronary disease.
    Park SJ; Ahn JM; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Choo SJ; Chung CH; Lee JW; Cohen DJ; Yeung AC; Hur SH; Seung KB; Ahn TH; Kwon HM; Lim DS; Rha SW; Jeong MH; Lee BK; Tresukosol D; Fu GS; Ong TK;
    N Engl J Med; 2015 Mar; 372(13):1204-12. PubMed ID: 25774645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies for multivessel revascularization in diabetes mellitus patients].
    Grille ÁC
    Rev Clin Esp (Barc); 2013; 213(6):307. PubMed ID: 24073430
    [No Abstract]   [Full Text] [Related]  

  • 20. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.
    Park DW; Kim YH; Yun SC; Song HG; Ahn JM; Oh JH; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    J Am Coll Cardiol; 2011 May; 57(21):2152-9. PubMed ID: 21596230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.